This resistance can occur because: (i) IFI27 overexpression may affect mitochondrial integrity differently in cancer cells, making them less prone to apoptotic signaling; (ii) some studies suggest that IFI27 may inhibit the apoptotic pathway in certain cancer cells, promoting survival even in the presence of DNA-damaging agents. The gene discussed is IFI27; the disease is cancer.